Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score–weighted comparative cohort study

Autor: Soleimani, Maryam, Zou, Kevin, Sunderland, Katherine, Struss, Werner, Eigl, Bernie J., Nappi, Lucia, Kollmannsberger, Christian K., Finch, Daygen, Noonan, Krista, Vergidis, Joanna, Zulfiqar, Muhammad, Chi, Kim N., Khalaf, Daniel J.
Zdroj: In European Journal of Cancer July 2021 152:215-222
Databáze: ScienceDirect
Externí odkaz: